SCHEMBL32669619

SCHEMBL32669619

CN(Cc1cc2c(cc1F)OCCO2)C(=O)/C(C#N)=C(\O)c1cc(Cl)c(O)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 2/20 0.36
FTO Q9C0B1 1/20 0.36
ABL1 P00519 1/20 0.33
RIN1 Q13671 1/20 0.33
HTT P42858 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
PKM P14618 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669732 0.91 COMT (0.34) COMTFTOABL1RIN1
SCHEMBL32669706 0.91 COMT (0.34) COMTFTOABL1RIN1
SCHEMBL32669847 0.84 COMT (0.39) COMTFTOHTTALDH1A1NPC1
SCHEMBL32670095 0.83 CTNNB1 (0.31) COMTFTO
SCHEMBL32669600 0.82 ALDH1A1 (0.39) COMTFTOALDH1A1NPC1RAB9A
SCHEMBL32669621 0.81 COMT (0.37) COMTFTOHTTALDH1A1MAOB
SCHEMBL32669498 0.81 COMT (0.39) COMTFTOHTTALDH1A1NPC1
SCHEMBL32669543 0.80 FFAR1 (0.37) COMTFTOHTTALDH1A1
SCHEMBL32669758 0.80 COMT (0.36) COMTFTOALDH1A1GAAHPGD
SCHEMBL32670065 0.80 MCL1 (0.38) COMTFTONPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 COMT 52/4885FTO 1/4885ABL1 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.